NCT01965756View on ClinicalTrials.gov

Effect of Insulin Sensitizer Metformin on AD Biomarkers

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

December 22, 2015

Study Completion Date

April 30, 2017

Conditions
Alzheimer's DiseaseVascular DementiaDementiaMemory Impairment
Interventions
DRUG

Metformin

DRUG

Placebos

Trial Locations (1)

19104

University of Pennsylvania, Penn Memory Center, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER

NCT01965756 - Effect of Insulin Sensitizer Metformin on AD Biomarkers | Biotech Hunter | Biotech Hunter